Refine by
Crispr Technology Articles & Analysis
36 news found
The company provides integrated animal cell research platforms, including custom animal cell-based assays, animal MSC secretome analysis, extracellular vesicle characterization, 3D culture development, CRISPR-related cell technologies, and customized animal cell line ...
ByBioVenic
Integrated drug discovery services combine biology, medicinal chemistry, pharmacology and other sciences with cutting-edge technology to create new therapeutic options. As an antiviral preclinical contract research organization, Creative Diagnostics has enhanced its ability to provide a full range of services from target identification and validation, lead generation & ...
CRISPR, a revolutionary gene editing technology, has transformed biological research by enabling precise and efficient manipulation of DNA. ...
This path-breaking move sees the integration of cutting-edge technology with state-of-art research facilities to amplify the possibilities of devising effective remedies for rare diseases. ...
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic ...
CD Genomics, a distinguished leader in genomics and sequencing services, has proudly unveiled its groundbreaking CRISPR Screen Sequencing technology. This innovative solution promises to expedite discoveries, facilitate target identification, and optimize drug development pipelines within the biotechnology and pharmaceutical industries. ...
After strict tests, this CRISPR Cas9 transfection reagent manifests high-efficiency delivery of the CRISPR/Cas9 system, even on primary and hard to transfect cells. ...
In recent years, CRISPR technology has significantly promoted the innovation of gene therapy for blood diseases, tumors, genetic diseases, and other diseases, which has become a powerful tool in the field of scientific research. However, the CRISPR technology was also demonstrated to consist of shortcomings, in which the 20 bp ...
Mammoth Biosciences, a biotech company harnessing next-generation CRISPR technology to detect and cure disease, has been chosen by Endpoints News Editor John Carroll as one of the most promising biotech startups for this year’s Endpoints 11 annual special report. ...
CRISPR QC leverages technology developed at his previous company, Cardea Bio, an EvoNexus graduate. ...
"CRISPR QC’s technology is empowering scientists to put the puzzle pieces together of CRISPR editing in a way that was not before possible. ...
“We are excited for CRISPR QC as they prepare for funding and growth.” Tweet this "This prestigious award acknowledges our commitment to helping improve the CRISPR gene editing process and being recognized for our technology and ability to provide previously unavailable and insightful data to scientists and researchers to better ...
. - the world’s only mass producer of biocompatible semiconductors - announced a significant milestone with the launch of CRISPR QC Inc. as a separate business using Cardea’s CRISPR-chip™ technology for a range of quality control services for CRISPR gene editing. ...
Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced that it has been named to Fast Company’s inaugural Next Big Things in Tech list for its application of CRISPR technology to its FDA-authorized COVID-19 testing kit. The list honors technology ...
“After a year of unprecedented growth and acceleration of our CRISPR and synthetic biology technologies, Sherlock is poised to disrupt diagnostics through the launch of real-world solutions that provide accurate, actionable health information wherever and whenever it is needed,” said Jim Collins, Ph.D., co-founder and board member of Sherlock ...
Food and Drug Administration in May 2020 for its Sherlock™ CRISPR SARS-CoV-2 kit – the first FDA-authorized use of CRISPR technology – The 221b Foundation has continued to increase access to the technology through partnerships around the world. ...
The 221b Foundation, a nonprofit organization established by Sherlock Biosciences to address the global COVID-19 pandemic while promoting diverse representation in STEM, today announced that it has granted a license to ALBOT USA and ALBOT Technologies Private Limited India to develop, manufacture and distribute COVID-19 diagnostic tests using Sherlock’s ...
“We believe that Sherlock’s CRISPR-based technology holds promise as a potential answer to high volume testing needs,” said Robert Carlson, M.D., medical director at NorDx. ...
When a specific sequence of DNA or RNA is present, a CRISPR enzyme is activated and, much like a pair of scissors, starts cutting nearby genetic material, releasing a fluorescent signal that indicates a positive result. ...
” Combining Sherlock’s proprietary CRISPR diagnostic technology with LogicInk’s DNA nanotechnology proprietary platform may enable entire populations to self-administer and screen for the presence of SARS-CoV-2 RNA (COVID-19) simply by identifying an appropriate color combination. ...